Bradley S. Quon, MD, MSc, MBA

Assistant Professor
Department of Medicine
UBC
Address: 

Centre for Heart Lung Innovation
St. Paul’s Hospital, Burrard Building
Room 166 - 1081 Burrard Street, Vancouver, B.C. V6Z 1Y6

 

Phone Number: 
(604) 806-8346 x68395
Fax Number: 
(604) 806-9274
Email Address: 

Dr. Quon received joint degrees in Medicine and Business Administration at McGill University, Montreal, Canada (2005), completed medical residency in Internal Medicine and Respiratory Medicine at the University of British Columbia (in 2010) and received a Master’s of Science degree in Clinical Epidemiology at the University of Washington, Seattle, USA (2012).

Dr. Quon began his academic appointment as Assistant Professor of Medicine at the University of British Columbia (UBC) in 2014. He is the inaugural recipient of the Cystic Fibrosis (CF) Canada – UBC Clinician Scientist Award. He is a Principal Investigator at the UBC Centre for Heart Lung Innovation and Research Director of the St. Paul’s Hospital Adult CF Clinic.

He is a Staff Respirologist and CF Physician at St. Paul’s Hospital in Vancouver. His research program focuses on the discovery of novel biomarkers to improve the care and diagnosis of patients with CF, which is the most common inherited fatal disease in Caucasians. Additionally, his research program focuses on CF-related co-morbidities that influence the quality of life and longevity of adults with CF.

Education and Training

  • MD and MBA, McGill University (2005)
  • MSc, University of Washington (2012)

Area of Interest

Dr. Quon is a clinician-scientist with a primary clinical and research interest in cystic fibrosis (CF). His research focuses on bridging discoveries in the basic laboratory into the clinic to improve patient outcomes. He is currently searching for novel biomarkers of inflammation and infection to improve disease monitoring in CF. He also has expertise in clinical epidemiology and is part of an international collaboration examining health outcomes for individuals with CF who live in Canada and the United States, using national registry data. He is also actively involved in several clinical trials investigating new therapies in CF, several of which have already transformed patient care. He is a Michael Smith Foundation for Health Research Scholar and is the Medical Director of the newly formed CF Canada Clinical Trial Network (CF CanACT).

Selected Publications